Vivanza Biosciences Limited (BOM:530057)
India · Delayed Price · Currency is INR 2.100
+0.100 (5.00%)
At close: Apr 16, 2026
Vivanza Biosciences Market Cap
Vivanza Biosciences has a market cap or net worth of 84 million as of April 17, 2026. Its market cap has decreased by -2.33% in one year.
Market Cap
84.00M
Enterprise Value
179.31M
Revenue
1.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
2.10
Market Cap Chart
Since October 23, 2012, Vivanza Biosciences's market cap has decreased from 178.64M to 84.00M, a decrease of -52.98%. That is a compound annual growth rate of -5.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 84.00M | -4.55% |
| Dec 31, 2025 | 88.00M | -35.67% |
| Dec 31, 2024 | 136.80M | -68.25% |
| Dec 29, 2023 | 430.80M | -30.96% |
| Dec 23, 2022 | 624.00M | -12.92% |
| Dec 27, 2021 | 716.60M | 59.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Norris Medicines | 147.51M |
| Desh Rakshak Aushdhalaya | 139.89M |
| Emmessar Biotech & Nutrition | 129.20M |
| Beryl Drugs | 120.96M |
| Shamrock Industrial Company | 115.99M |
| Colinz Laboratories | 114.62M |
| Ortin Global | 106.20M |
| Unjha Formulations | 91.81M |